← Leaderboards
Ivan Vesely
Cleveland Clinic Foundation
$7,507,300
Attributed
$7,507,300
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,507,300 · 7
By mechanism
R01$4,267,129 · 4
R44$2,992,298 · 2
R41$247,873 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Kurt W Runge$10,236,593
- Kathleen Lucile Berkner$10,955,430
- Shuvo Roy$13,352,350
Others in their field
Top investigators on “Animal Tissue”
- David Heimbrook · Leidos Biomedical Research, Inc.$154,832,039
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$58,226,498
- Joseph E Robertson · Oregon Health & Science University$53,773,205
- Sarah Fortune · Harvard School Of Public Health$51,119,645
Research focus
Animal TissueAortic ValveBiomaterial EvaluationElastinCollagenElasticityTensile StrengthScanning Electron MicroscopyBiomaterial Development /PreparationBiomechanicsProsthetic Heart ValveCardiac Surgery ProceduresDesignAnticoagulationCathetersDevicesHeartGenerationsAnimalsBioprosthesis DeviceHealedAnimal ModelAnticoagulantsDocking
Grant awards (21)
Beating-Heart Surgery for Heart Valve Replacement$1,077,042
R44 · FY2012 · HL · contact PI
Anti-fibrotic Coatings for Rapidly Exchangeable Bioprosthetic Heart Valve$332,704
R44 · FY2010 · HL · contact PI
Beating-Heart Surgery for Heart Valve Replacement$299,218
R44 · FY2010 · HL · contact PI
Anti-fibrotic Coatings for Rapidly Exchangeable Bioprosthetic Heart Valve$1,283,334
R44 · FY2008 · HL · contact PI
Exchangeable Heart Valve for Tissue Engineering Applications$247,873
R41 · FY2007 · HL · contact PI
A Composite Tissue-engineered Aortic Valve Prosthesis$272,277
R01 · FY2006 · HL · contact PI
A Composite Tissue-engineered Aortic Valve Prosthesis$99,525
R01 · FY2006 · HL · contact PI
A Composite Tissue-engineered Aortic Valve Prosthesis$380,750
R01 · FY2005 · HL
Micromechanics of the Aortic Valve:Durability Testing$190,375
R01 · FY2005 · EB
A Composite Tissue-engineered Aortic Valve Prosthesis$456,900
R01 · FY2004 · HL
Micromechanics of the Aortic Valve:Durability Testing$380,750
R01 · FY2004 · EB
A Composite Tissue-engineered Aortic Valve Prosthesis$371,667
R01 · FY2003 · HL
Micromechanics of the Aortic Valve:Durability Testing$222,896
R01 · FY2003 · EB
Micromechanics of the Aortic Valve:Durability Testing$156,067
R01 · FY2003 · EB
A Composite Tissue-engineered Aortic Valve Prosthesis$74,500
R01 · FY2003 · HL
Micromechanics of the Aortic Valve:Durability Testing$370,000
R01 · FY2002 · HL
ELASTIN DAMAGE: MECHANISM OF BIOPROSTHETIC VALUE FAILURE$222,000
R01 · FY2002 · HL
MICROMECHANICS OF THE AORTIC VALVE$317,333
R01 · FY2001 · HL
ELASTIN CAMAGE: MECHANISM OF BIOPROSTHETIC VALUE FAILURE$222,000
R01 · FY2001 · HL
MICROMECHANICS OF THE AORTIC VALVE$308,089
R01 · FY2000 · HL
ELASTIN CAMAGE: MECHANISM OF BIOPROSTHETIC VALUE FAILURE$222,000
R01 · FY2000 · HL